Anti-Human CD52 Recombinant Antibody(Tarextumab)

Name: Anti-Human CD52 Recombinant Antibody(Tarextumab)
Brand: KMD Bioscience
SKU: YR1312

YR1312

科研级 Tarextumab ( 他瑞妥单抗 ), Anti-CD52 Recombinant Antibody, Research Grade Tarextumab

DATASHEET MSDS

Product Description

Alias	科研级 Tarextumab ( 他瑞妥单抗 ), Anti-CD52 Recombinant Antibody, Research Grade Tarextumab
Catalog Number	YR1312
Molecular Name	Tarextumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa Lambda
Formulation	PBS, pH7.5
Background	Tarextumab (formerly OMP-59R5) is a fully human monoclonal antibody targeting the Notch 2/3 receptors. It is being tested as a possible treatment for cancer. In January 2015, the US FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and lung cancer. Two early stage clinical trials have reported encouraging results.
CAS Number	1359940-55-8
Application	IF, IP, Neut, FuncS, ELISA, FCM
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD52[Homo sapiens]

Login